These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 24685633

  • 1. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
    Cadena-del-Castillo C, Valdes-Quezada C, Carmona-Aldana F, Arias C, Bermúdez-Rattoni F, Recillas-Targa F.
    J Alzheimers Dis; 2014; 41(3):845-54. PubMed ID: 24685633
    [Abstract] [Full Text] [Related]

  • 2. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
    Bedse G, Romano A, Cianci S, Lavecchia AM, Lorenzo P, Elphick MR, Laferla FM, Vendemiale G, Grillo C, Altieri F, Cassano T, Gaetani S.
    J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
    [Abstract] [Full Text] [Related]

  • 3. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M, Mian MF, Michalski B, Azam AB, Ma D, Salwierz P, Christopher A, Rosa E, Zovkic IB, Forsythe P, Fahnestock M, Sakic B.
    J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
    [Abstract] [Full Text] [Related]

  • 4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 5. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S, Madan M, Okun E, Wei Z, Pattisapu JV, Mughal MR, Mattson MP, Chan SL.
    J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
    [Abstract] [Full Text] [Related]

  • 6. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP, Cerón-Solano G, Velázquez-Campos G, Pacheco-López G, Bermúdez-Rattoni F, Díaz-Cintra S.
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [Abstract] [Full Text] [Related]

  • 7. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 8. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Nov; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

  • 9. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM, Alata W, Dodacki A, Traversy MT, Chacun H, Pradier L, Scherrmann JM, Farinotti R, Calon F, Bourasset F.
    Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
    [Abstract] [Full Text] [Related]

  • 10. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K, Moreno-Castilla P, Castro-Cruz M, McGaugh JL, Martínez-Coria H, LaFerla FM, Bermúdez-Rattoni F.
    Learn Mem; 2012 Sep 14; 19(10):453-60. PubMed ID: 22984283
    [Abstract] [Full Text] [Related]

  • 11. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
    Mota SI, Ferreira IL, Valero J, Ferreiro E, Carvalho AL, Oliveira CR, Rego AC.
    Exp Neurol; 2014 Nov 14; 261():698-709. PubMed ID: 25128699
    [Abstract] [Full Text] [Related]

  • 12. Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
    Lee DY, Moon J, Lee ST, Jung KH, Park DK, Yoo JS, Sunwoo JS, Byun JI, Shin JW, Jeon D, Jung KY, Kim M, Lee SK, Chu K.
    J Alzheimers Dis; 2015 Nov 14; 45(3):837-49. PubMed ID: 25624420
    [Abstract] [Full Text] [Related]

  • 13. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Nov 14; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 14. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
    Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M.
    Neurobiol Aging; 2014 Jun 14; 35(6):1334-44. PubMed ID: 24387984
    [Abstract] [Full Text] [Related]

  • 15. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y, Zhao Y, Dai CL, Liang Z, Run X, Iqbal K, Liu F, Gong CX.
    Exp Neurol; 2014 Nov 14; 261():610-9. PubMed ID: 24918340
    [Abstract] [Full Text] [Related]

  • 16. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
    Orta-Salazar E, Aguilar-Vázquez A, Martínez-Coria H, Luquín-De Anda S, Rivera-Cervantes M, Beas-Zarate C, Feria-Velasco A, Díaz-Cintra S.
    Life Sci; 2014 Oct 29; 116(2):83-9. PubMed ID: 25261598
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J, Lebbadi M, Tremblay C, St-Amour I, Pierrisnard C, Faucher-Genest A, Emond V, Julien C, Calon F.
    Synapse; 2018 Apr 29; 72(4):. PubMed ID: 29341269
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G, Di Benedetto G, Puzzo D, Privitera L, Loreto C, Saccone S, Giunta S, Palmeri A, Bernardini R.
    Brain; 2015 Jan 29; 138(Pt 1):203-16. PubMed ID: 25472798
    [Abstract] [Full Text] [Related]

  • 20. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X, Ren X, Huang P, Li S, Ma Q, Ying M, Ni J, Liu J, Yang X.
    J Alzheimers Dis; 2014 Jan 29; 40(3):575-86. PubMed ID: 24496070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.